Patient Opportunity Trust Class FI
LMOFX
NASDAQ
Weiss Ratings | LMOFX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Fair | |||
Reward Grade | C | |||
Risk Index | Weak | |||
Risk Grade | D+ | |||
Company Info | LMOFX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Provider | Patient Capital Management | |||
Manager/Tenure (Years) | Samantha McLemore (16), Christina Malbon (2) | |||
Website | http://www.patientcapitalmanagement.com | |||
Fund Information | LMOFX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Fund Name | Patient Opportunity Trust Class FI | |||
Category | Mid-Cap Value | |||
Sub-Category | US Equity Mid Cap | |||
Prospectus Objective | Growth | |||
Inception Date | Feb 13, 2004 | |||
Open/Closed To New Investors | Open | |||
Minimum Initial Investment | 0.00 | |||
Minimum Subsequent Investment | -- | |||
Front End Fee | -- | |||
Back End Fee | -- | |||
Dividends and Shares | LMOFX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Yield | 0.00% | |||
Dividend | LMOFX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Yield (Forward) | 1.53% | |||
Asset Allocation | LMOFX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Cash | -0.67% | |||
Stock | 97.10% | |||
U.S. Stock | 86.99% | |||
Non-U.S. Stock | 10.11% | |||
Bond | 0.00% | |||
U.S. Bond | 0.00% | |||
Non-U.S. Bond | 0.00% | |||
Preferred | 1.24% | |||
Convertible | 0.00% | |||
Other Net | 2.33% | |||
Price History | LMOFX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | 0.07% | |||
30-Day Total Return | 4.84% | |||
60-Day Total Return | 23.25% | |||
90-Day Total Return | 6.46% | |||
Year to Date Total Return | 1.52% | |||
1-Year Total Return | 16.20% | |||
2-Year Total Return | 45.10% | |||
3-Year Total Return | 73.20% | |||
5-Year Total Return | 69.65% | |||
Price | LMOFX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Closing Price | -- | |||
1-Month Low Price | -- | |||
1-Month High Price | -- | |||
52-Week Low Price | -- | |||
52-Week Low Price (Date) | -- | |||
52-Week High Price | -- | |||
52-Week High Price (Date) | -- | |||
NAV | LMOFX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Nav | -- | |||
1-Month Low NAV | $36.95 | |||
1-Month High NAV | $40.21 | |||
52-Week Low NAV | $30.31 | |||
52-Week Low NAV (Date) | Apr 08, 2025 | |||
52-Week High NAV | $42.76 | |||
52-Week High Price (Date) | Feb 18, 2025 | |||
Beta / Standard Deviation | LMOFX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 1.59 | |||
Standard Deviation | 29.93 | |||
Balance Sheet | LMOFX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Total Assets | 1.44B | |||
Operating Ratios | LMOFX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Expense Ratio | 1.82% | |||
Turnover Ratio | 31.00% | |||
Performance | LMOFX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Last Bull Market Total Return | 24.34% | |||
Last Bear Market Total Return | -29.50% | |||